A pH-Sensitive Nano Drug Delivery System Derived From Pullulan/Doxorubicin Conjugate

被引:81
作者
Lu, Dianxiang [1 ]
Wen, Xiantao [1 ]
Liang, Jie [1 ]
Gu, Zhongwei [1 ]
Zhang, Xingdong [1 ]
Fan, Yujiang [1 ]
机构
[1] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China
关键词
drug delivery/release; controlled release; nanomedicine; nanoassembled devices; tumor; IN-VITRO; CONTROLLED ACTIVATION; CHOLESTERYL PULLULAN; ANTICANCER DRUGS; DOXORUBICIN; NANOPARTICLES; POLYMER; CANCER; RELEASE; CARRIER;
D O I
10.1002/jbm.b.31203
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
A novel pH-sensitive nanoparticle drug delivery system for doxorubicin (DOX) is prepared. Pullulan, a natural biocompatible polysaccharide, was partly carboxymethylized; hydrazine hydrate was condensed with the carboxyl groups forming hydrazide. The hydrazide was coupled with DOX through the formation of hydrazone bond. The chemical structure of the conjugate was determined by FTIR and H-1 NMR. The pullulan/DOX conjugate nanoparticles were formed through the aggregation of hydrophobic DOX. The size and morphology of prepared nanoparticles were characterized using dynamic light scattering and transmission electron microscope. The results showed that the nanoparticles were spherical and their size was less than 100 lint. The content of DOX in conjugate was 3.18 wt %. The investigation of the release behavior in vitro indicated that the DOX was released from nanoparticles faster at pH 5.0 (62% DOX released within 24 h) than at pH 7.4 (29% DOX released within 24 h). The in vitro cytotoxicity of pullulan/DOX conjugate nanoparticles was tested by the MTT assay. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res Part B. Appl Biomater 89B: 177-183, 2009
引用
收藏
页码:177 / 183
页数:7
相关论文
共 43 条
[11]
2-#
[12]
The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity [J].
Fritzsche, Juliane ;
Alban, Susanne ;
Ludwig, Ralf J. ;
Rubant, Simone ;
Boehncke, Wolf-Henning ;
Schumacher, Gabriele ;
Bendas, Gerd .
BIOCHEMICAL PHARMACOLOGY, 2006, 72 (04) :474-485
[13]
Pullulan-cyclodextrin microspheres - A chromatographic approach for the evaluation of the drug-cyclodextrin interactions and the determination of the drug release profiles [J].
Fundueanu, G ;
Constantin, M ;
Mihai, D ;
Bortolotti, F ;
Cortesi, R ;
Ascenzi, P ;
Menegatti, E .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 791 (1-2) :407-419
[14]
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy [J].
Garsky, VM ;
Lumma, PK ;
Feng, DM ;
Wai, J ;
Ramjit, HG ;
Sardana, MK ;
Oliff, A ;
Jones, RE ;
DeFeo-Jones, D ;
Freidinger, RM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) :4216-4224
[15]
Determination of substituents distribution in carboxymethylpullulans by NMR spectroscopy [J].
Glinel, K ;
Sauvage, JP ;
Oulyadi, H ;
Huguet, J .
CARBOHYDRATE RESEARCH, 2000, 328 (03) :343-354
[16]
Selective and effective cytotoxicity of folic acid-conjugated cholesteryl pullulan hydrogel nanoparticles complexed with doxorubicin in in vitro and in vivo studies [J].
Hidaka, Masaaki ;
Kanematsu, Takashi ;
Ushio, Kazutoshi ;
Sunamoto, Junzo .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2006, 21 (06) :591-602
[17]
Dextrins as carriers for drug targeting: Reproducible succinoylation as a means to introduce pendant groups [J].
Hreczuk-Hirst, D ;
German, L ;
Duncan, R .
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, 2001, 16 (05) :353-365
[18]
Polymeric micellar pH-sensitive drug delivery system for doxorubicin [J].
Hruby, M ;
Konák, C ;
Ulbrich, K .
JOURNAL OF CONTROLLED RELEASE, 2005, 103 (01) :137-148
[19]
Ichinose K, 1998, ANTICANCER RES, V18, P401
[20]
Safety studies of a novel starch, pullulan: Chronic toxicity in rats and bacterial mutagenicity [J].
Kimoto, T ;
Shibuya, T ;
Shiobara, S .
FOOD AND CHEMICAL TOXICOLOGY, 1997, 35 (3-4) :323-329